Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Drug Discovery

Background:

• DNA alkylating agents are crucial in cancer therapy.
• Understanding sequence specificity is vital for targeted drug development.
• Polybenzamide mustards are a class of DNA minor groove binders.

Purpose of the Study:

• To investigate structure-activity relationships of polybenzamide mustards for sequence-specific DNA alkylation.
• To identify key molecular features governing DNA sequence recognition and alkylation.
• To inform the design of novel DNA-targeted therapeutic agents.

Main Methods:

• Synthesis and testing of a series of cytotoxic polybenzamide mustards.
• Evaluation of DNA alkylation patterns using sequence-specific assays.
• Computational modeling to elucidate binding interactions and alkylation mechanisms.

Main Results:

• Compounds with optimal annular structure and concave-facing NH groups preferentially alkylated adenine-rich sequences (AAAA).
• Compounds with outward-facing carboxamide NH groups showed specificity for the (A/T)A(G/C)(A/T)N consensus sequence.
• Specific guanine alkylation was observed, likely at the N3 position.
• Hydrogen bonding interactions were identified as the primary driver of sequence specificity, outweighing charge effects.

Conclusions:

• The precise fit of polybenzamide mustards to the DNA minor groove, coupled with hydrogen bonding, dictates sequence-specific alkylation.
• Drug design can be optimized by controlling compound shape and hydrogen-bonding potential for targeted DNA modification.
• These findings provide a foundation for developing more selective and effective DNA-targeting chemotherapeutics.